Machine Learning Hepion Pharmaceuticals Expands SAB with Appointments of Four Liver Disease KOLs GlobeNewswire Mar 31, 2023 Hepion Pharmaceuticals, a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for…
Technology Hepion Pharmaceuticals to Deliver Updates on Ongoing Phase 2 NASH Clinical Program with Rencofilstat… PR Newswire Mar 5, 2023 Hepion Pharmaceuticals, a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for…
Machine Learning Presentation of Preclinical Study Highlighting Anti-Cancer Activity of Rencofilstat in Combination… AIT News Desk Jan 11, 2023 Hepion Pharmaceuticals, a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for…